Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease. (Q51970686)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 October 2007

Language	Label	Description	Also known as
English	Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.	scientific article published on 9 October 2007

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

M C Irizarry

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

Y Yao

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

B T Hyman

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

J H Growdon

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

D Praticò

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

publication date

9 October 2007

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

Neurodegenerative Diseases

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

6

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

403-405

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Increased CSF F2-isoprostane concentration in probable AD.

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Diagnostic criteria for Parkinson disease

1 reference

https://api.crossref.org/works/10.1159%2F000107699

21 January 2018

Identifiers

10.1159/000107699

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/17934322

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51970686&oldid=1236839398"